Large-scale diversion of controlled substances (CS) from within a hospital or heath system pharmacy is a rare but growing problem. It is the responsibility of pharmacy leadership to scrutinize control processes to expose weaknesses. This article reviews examples of large-scale diversion incidents and diversion techniques and provides practical strategies to stimulate enhanced CS security within the pharmacy staff. Large-scale diversion from within a pharmacy department can be averted by a pharmacist-in-charge who is informed and proactive in taking effective countermeasures.
BogardusDE. Drug Diversion in Healthcare – A Guide to Identification and Prevention. Marblehead: Opus Communications; 2002.
3.
SiegalJO'NealB.Prevention of controlled substance diversion – scope, strategy, and tactics. Code N: multidisciplinary approach to proactive drug diversion prevention. Hosp Pharm.2007;42(3):244–248.
4.
O'NealBSiegalJ.Prevention of controlled substance diversion – scope, strategy, and tactics. Diversion in the operating room. Hosp Pharm.2007;42(4):359–367.
5.
SiegalJ. Prevention of controlled substance diversion – scope, strategy, and tactics. The investigative process. Hosp Pharm.2007;42(5):466–469.
6.
O'NealBSiegalJ.Prevention of controlled substance diversion – scope, strategy, and tactics. Use of diversion detection software. Hosp Pharm.2007;42(6):564–571.
7.
SiegalJO'NealB.Prevention of controlled substance diversion – scope, strategy, and tactics. Code N: The intervention process. Hosp Pharm.2007;42(7):653–656.
8.
FlemingK. A novel approach to monitoring the diversion of controlled substances: the role of the pharmacy compliance officer. Hosp Pharm.2007;42(3):200–208, 225.
9.
O'NealBSiegalJ.Prevention of controlled substance diversion – scope, strategy, and tactics. Diversion in the pharmacy. Hosp Pharm.2007;42(2):145–148.
